464 Impact of up to 6 Months of Mepolizumab Treatment for Adolescents and Adults With Eosinophilic Esophagitis in the Second Phase of a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial
Year: 2023
Type: article
Source: Gastroenterology
Language: English
Topic: Eosinophilic Esophagitis
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4383421609
